Description

The white paper, The UCB-Celltech Merger – A Strategic Snapshot, includes the details of the merger, stock analysis, and product pipeline analysis of Celltech. The white paper includes analysis of Celltech's lead product CDP-870 and its market potential, rheumatoid arthritis and Crohn’s disease market overview, competitive analysis of biologics for rheumatoid arthritis, and impact of the merger on pharmaceutical and biotechnology industry